mouse |
LD50 |
intramuscular |
> 2gm/kg (2000mg/kg) |
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Chemotherapy Vol. 34(Suppl, |
mouse |
LD50 |
intraperitoneal |
1531mg/kg (1531mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 31(Suppl, |
mouse |
LD50 |
intravenous |
348mg/kg (348mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Chemotherapy Vol. 34(Suppl, |
mouse |
LD50 |
oral |
4526mg/kg (4526mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 31(Suppl, |
mouse |
LD50 |
subcutaneous |
2185mg/kg (2185mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 31(Suppl, |
rat |
LD50 |
intramuscular |
1680mg/kg (1680mg/kg) |
SKIN AND APPENDAGES (SKIN): HAIR: OTHER |
Chemotherapy Vol. 34(Suppl, |
rat |
LD50 |
intraperitoneal |
1399mg/kg (1399mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 31(Suppl, |
rat |
LD50 |
intravenous |
326mg/kg (326mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Chemotherapy Vol. 34(Suppl, |
rat |
LD50 |
oral |
7936mg/kg (7936mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 31(Suppl, |
rat |
LD50 |
subcutaneous |
1398mg/kg (1398mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 31(Suppl, |